MFMehdi Farhoudi

Mehdi Farhoudi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mehdi Farhoudi has a total of 867 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Increased stroke risk in patients with Alopecia Areata: A systematic review and meta-analysis

    by Sama Rahnemayan, Mehdi Farhoudi, Sasan Ghazanfar Ahari

  • Open Access

    Intravenous Thrombolysis for Acute Ischemic Stroke Across the Middle East and North Africa (2021–2023): Results from the SITS-MENA Registry

    by Maria Khan, Marius Matusevicius, Suhail AlRukn, Abdoreza Ghoreishi, Mehdi Farhoudi, Elyar Sadeghi Hokmabadi, Payam Sariaslani, Tamer Roushdy, Naveed Akhtar, Yahia Imam, et al.

    Background: Intravenous thrombolysis (IVT) for acute ischemic stroke in the Middle-East and North African (MENA) countries has increased in the last decade, but long-term outcomes and quality of care are less well studied. Methods: This was a prospective observational study to examine 3-month outcomes of IVT-treated patients in MENA stroke units using the SITS Registry. Findings: There were 2768 patients in MENA and 7163 patents in non-MENA treated with IVT and registered in SITS between August 2021 and September 2023. Compared to non-MENA, MENA patients were younger (65 vs 72 years-old), had higher NIH Stroke Scale scores at baseline (11 vs 9) and shorter door-to-needle times (30 vs 54 min). The most common risk factors in MENA were hypertension (64.9 vs 69.8 %) and diabetes (30.8 vs 20.1%). Functional independence at 3 months was similar (56.6% vs 57.7%); however, mortality at 7 and 30 days was significantly higher in MENA (8.3% vs 5.3% and 20.7 vs 14.5%). Symptomatic intracranial hemorrhage rates were low in both groups (<1.2% per SITS-MOST). Early mortality rates related to stroke were comparable (56.7 vs 59.2%) but early deaths caused by myocardial infarction, pneumonia, pulmonary embolism and sepsis were more frequent in MENA (14.2 vs 4.6%, 6.7 vs 4.6%, 1.5 vs 0.4% and 3 vs 1.8%). Interpretation: The overall mortality of IVT-treated patients was increased in MENA at 7 and 90 days post-stroke. Differences in risk factors at baseline may account for mortality but the treatment of medical complications in MENA stroke units warrants further study.

  • Open Access

    Air Pollution and Risk of Stroke: A Multi-Year Analysis of PM2.5 and Other Pollutants in Tabriz, Iran

    by Fereshteh Asadi, Fatemeh Masaebi, Mahdi Maqboli, Mehdi Farhoudi, Mohammad Reza Mehrasbi

  • Open Access

    Circulating IncRNAs and Their Association With Ischemic Stroke Severity and Prognosis: A Systematic Review and Meta‐Analysis

    by Mehran Jaberinezhad, Parnia Pouya, Anahita Najafi, Arman Shafiee, Saba Maleki, Parnian Shobeiri, Antonio L. Teixeira, Mehdi Farhoudi

    Background and Aims: Stroke is the most significant contributor to morbidity worldwide. Prognostication in stroke patients could lead to better planning and care and, subsequently, better outcomes. Recently, lncRNAs have become a hot topic as biomarkers of different diseases. This study aims to systematically assess the utility of lncRNAs in stroke prognosis. Methods: We systematically searched for relevant articles in Medline (via PubMed interface), EMBASE, Web of Science, and Scopus databases from their inception to April 6th, 2024. Inclusions were limited to original peer‐reviewed papers in English that assessed the correlation between circulating lncRNA levels and stroke severity (all subtypes) and/or prognosis. Completeness of the report was evaluated with the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) checklist, and quality assessment was performed with “Quality in Prognosis Studies” (QUIPS) and “Newcastle Ottawa scale” (NOS) checklists. Results: Of the 1134 unique citations gathered, 60 were assessed in full text for inclusion, and 30 were included in the final analysis. Although our search strategy covered all stroke subtypes, no eligible studies were found for hemorrhagic stroke; thus, only ischemic stroke and TIA populations were included. We included 30 studies in our analysis, which included 3719 patients and 4433 data points. The pooled correlation between circulating lncRNAs and NIHSS was 0.52 (CI95%:0.43–0.60), and circulating lncRNAs and the modified Rankin Scale was 0.49 (CI95%:0.26–0.67). The pooled odds ratio for the mortality prediction was 1.55 (CI 95%:1.26–1.92). Quality assessment of included studies showed that most of the studies had a low risk of bias and high completeness of report. Conclusion: LncRNAs show modest to moderate predictive accuracy in assessing stroke severity and prognosis. While these findings are encouraging, Further research is needed to solidify their utility in stroke care.

  • Dose-dependent neurotoxic impact of cigarette smoking on post-stroke survival

    by Ali Bahari, Neda Gilani, Elyar Sadeghi-Hokmabadi, Arezoo Fathalizadeh, Mehdi Farhoudi

  • 4-aminopyridine exerts anxiolytic and pro-cognitive effects in mice model of medial prefrontal cortex ischemia

    by Esmaeil Imani-Almas, Javad Mahmoudi, Mehdi Farhoudi, Saeed Sadigh-Eteghad, Abbas Ebrahimi-Kalan

    Brain ischemia is a major global cause of disability, frequently leading to psychoneurological issues. This study investigates the effects of 4-aminopyridine (4-AP) on anxiety, cognitive impairment, and potential underlying mechanisms in a mouse model of medial prefrontal cortex (mPFC) ischemia. Mice with mPFC ischemia were treated with normal saline (NS) or different doses of 4-AP (250, 500, and 1000 µg/kg) for 14 consecutive days. The open field test, elevated plus maze, Barnes maze, and novel object recognition test were used to perform a series of behavioral assessments to evaluate anxiety as well as spatial and episodic memory. Serum corticosterone levels and changes in oxidative stress markers (MDA, SOD, GPx, and TAC) were measured by ELISA. Inflammatory and apoptotic markers (p-P38, NF-κB, IL-1β, TNF-α, p-PI3K, p-AKT, Caspase-3, BAX, and BCL2) were analyzed via western blotting. Results showed that mPFC ischemia induced anxiety-like behavior and disrupted both recognition and spatial memory at the behavioral level. Additionally, ischemia increased serum corticosterone levels, elevated oxidative stress, and upregulated inflammatory and apoptotic markers. However, 4-AP at the highest dose significantly mitigated these behavioral and molecular deficits. These findings suggest that 4-AP alleviates anxiety-like behavior and cognitive impairment associated with mPFC ischemia, possibly through modulation of corticosterone, oxidative stress, inflammation, and apoptotic signaling pathways.

  • Open Access

    Intranasal Autologous Conditioned Serum Attenuates Memory Impairment After mPFC Ischemia in Mice

    by Sareh Kazmi, Neda Yazdanfar, Fatemehsadat Seyedaghamiri, Alireza Pishgahi, Mehdi Yousefi, Tahereh Ghadiri, Saeed Sadigh-Eteghad, Mehdi Farhoudi

    Introduction: Globally, stroke ranks as the second most prevalent cause of death, contributing significantly to worldwide mortality burdens, imposing a significant economic and emotional challenge on societies. This study was designed to investigate the effect of autologous conditioned serum (ACS) on memory and associated molecular factors in a mouse model of photothrombotic ...

  • Open Access

    Post-stroke Urinary Tract Infections and Their Outcome: A Clinico-microbiological and Epidemiological Analysis based on A Stroke Registry

    by Naeimeh Hosseinzadeh, Aytak Khabbaz, Somayeh Ahmadi, Seyyed Sina Hejazian, Hanieh Salehi-Pourmehr, Roqaiyeh Hasani, Fateme Tahmasbi, Robab Mehdizadeh, Saba Torabi, Mehdi Farhoudi, et al.

    Background: Urinary tract infections (UTIs) are common among hospitalized stroke patients, leading to increased hospital stays and patient discomfort. While it’s known that post-stroke infections generally worsen outcomes, specific factors contributing to UTIs after stroke remain unclear. Methods: This study aimed to investigate the incidence of post-stroke UTI (PSUTI) in patients admitted to the Hospitals from September 2020 to June 2021. The study included patients with a suspected diagnosis of stroke at the time of initial visit by a specialist. The final diagnosis was approved by an experienced neurologist and radiologist according to their brain CT scan. Data was collected from patients’ files, including demographics, comorbidities, drug history, smoking history, admission unit, clinical manifestations, systolic and diastolic blood pressure, type of stroke, etiology, laboratory findings, admission unit, in-hospital stay duration, therapies, use of NG tubes, urinary catheters, CV lines, brain drain, intratracheal tube, chest tube, dialysis catheter, and their durations. Results: A study involving 612 patients found that PSUTI-positive patients had worse conditions at admission, with ischemic stroke being more common. They had longer stays in the ward or ICU, and were more likely to have a death outcome. The most common pathogen was Escherichia coli, followed by Staphylococcus epidermidis, Enterococcus spp, and Pseudomonas aeruginosa. In-hospital complications were more prevalent in PSUTI-positive patients, except for hydrocephalus and pulmonary embolism. Positive history of diabetes, falling symptoms, urinary catheter, and intubation were independent risk factors for post-stroke UTI. Conclusion: The study highlights the impact of urinary tract infections (UTIs) on stroke outcomes, revealing severe clinical profiles, comorbidities, longer hospital stays, and increased invasive interventions. Key risk factors like diabetes and urinary catheter use highlight the need for vigilant monitoring and tailored management strategies.


  • Open Access

    Factors affecting the survival of stroke patients in the last eight years using parametric and non-parametric models: A study in the northwest of Iran

    by Mehdi Farhoudi, Neda Gilani, Ali Bahari, Elyar Sadeghi-Hokmabadi

    Background. The aim of this study was to evaluate factors affecting the survival of 5,430 stroke patients in the northwest of Iran using parametric and non-parametric models of survival analysis. Methods. This longitudinal school-based study was retrospectively conducted using the registered data of 5,430 stroke patients in Tabriz. The Akaike criterion and Cox-Snell residual diagram were used to evaluate the parametric models, and the Kaplan-Meyer curve was employed for assessing the non-parametric model. Analyses were performed using STATA17. Results. The findings demonstrated that different factors were associated with an increased risk of death from stroke, including the age group of 65 and older (proportional hazard [PH]= 1.75 and P<0.001), snoring (PH=1.34 and P= 0.005), addiction (PH= 1.87 and P= 0.007), smoking (PH= 5.94 and P< 0.001), and hookah use (PH = 1.81 and P= 0.005). The other related factors were diabetes (PH= 1.46 and P= 0.001), aspiration pneumonia (PH = 2.09 and P < 0.001), atrial fibrillation (PH= 1.59 and P= 0.002), systolic hypertension (PH= 3.15 and P< 0.001), and high triglyceride (PH = 1.33 and P= 0.012). Considering the frailty, the fitness of the Weibull model was better than that of the other models. Conclusion. According to the findings, snoring and having aspiration pneumonia were two important risk factors related to the survival of stroke patients. It is also recommended that the parametric models of survival analysis be used if the relevant assumptions are established. Practical Implications. The risk factors determined in the present study can be utilized in determining relevant interventions. It is recommended that identification programs such as screening and treatment of patients be implemented in this respect.

  • Open Access

    Transcranial Direct Current Stimulation and Mindfulness for Cognitive and Mood Recovery in Stroke Survivors: A Pilot Randomized Controlled Study

    by Atekeh Mosannaei Najibi, Sama Rahnemayan, Alireza Poursoleimani, Rasoul Heshmati, Mohammad Ali Nazari, Erfan Golshan Shali, Ehsan Nasiri, Mehdi Farhoudi

    Background: Cognitive impairments and depression are common after stroke. Noninvasive treatments like transcranial direct current stimulation (tDCS) and mindfulness‐based interventions have shown potential for improving these outcomes, though their effects on stroke survivors remain unclear. This study is aimed at evaluating the efficacy of mindfulness and tDCS in enhancing cognitive function and alleviating depression in stroke survivors. Methods: This randomized controlled trial, conducted from July 2021 to July 2022, included 30 stroke survivors divided into three groups: mindfulness ( n = 5), tDCS ( n = 14), and control ( n = 11). Cognitive function was measured using Addenbrooke’s Cognitive Examination‐III (ACE‐III), and depression was assessed using the Beck Depression Inventory‐II (BDI‐II) before and after interventions. The tDCS group received 10 sessions of anodal stimulation, and the mindfulness group underwent eight weekly sessions of mindfulness‐based stress reduction. Data were analyzed using paired t ‐tests for within‐group comparisons and ANOVA for between‐group differences. Results: The tDCS group showed significant improvement in cognitive function, with ACE‐III scores increasing by 9.14 ± 8.24 points ( p = 0.02). Fluency and orientation scores also improved significantly in this group ( p < 0.001 and p = 0.01, respectively). No significant cognitive changes were observed in the mindfulness group. Depression scores (BDI‐II) did not change significantly in any group. Conclusions: tDCS significantly improved cognitive performance, particularly in fluency and orientation, while mindfulness showed no significant cognitive or depression‐related effects. Future studies should explore the long‐term impact of these interventions in stroke rehabilitation. Trial Registration: ClinicalTrials.gov identifier: IRCT20090716002195N3